These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9862081)

  • 1. Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.
    Gouzoulis-Mayfrank E; Heekeren K; Thelen B; Lindenblatt H; Kovar KA; Sass H; Geyer MA
    Behav Pharmacol; 1998 Nov; 9(7):561-6. PubMed ID: 9862081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.
    Vollenweider FX; Csomor PA; Knappe B; Geyer MA; Quednow BB
    Neuropsychopharmacology; 2007 Sep; 32(9):1876-87. PubMed ID: 17299516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
    Heekeren K; Neukirch A; Daumann J; Stoll M; Obradovic M; Kovar KA; Geyer MA; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2007 May; 21(3):312-20. PubMed ID: 17591658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.
    Quednow BB; Kometer M; Geyer MA; Vollenweider FX
    Neuropsychopharmacology; 2012 Feb; 37(3):630-40. PubMed ID: 21956447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of melatonin on prepulse inhibition, habituation and sensitization of the human startle reflex in healthy volunteers.
    Lehtinen EK; Ucar E; Glenthøj BY; Oranje B
    Psychiatry Res; 2014 May; 216(3):418-23. PubMed ID: 24613047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine.
    Quednow BB; Wagner M; Westheide J; Beckmann K; Bliesener N; Maier W; Kühn KU
    Biol Psychiatry; 2006 Mar; 59(6):536-45. PubMed ID: 16139819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial.
    Wynn JK; Green MF; Sprock J; Light GA; Widmark C; Reist C; Erhart S; Marder SR; Mintz J; Braff DL
    Schizophr Res; 2007 Sep; 95(1-3):134-42. PubMed ID: 17662577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia.
    Ludewig K; Geyer MA; Vollenweider FX
    Biol Psychiatry; 2003 Jul; 54(2):121-8. PubMed ID: 12873801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.
    Liechti ME; Geyer MA; Hell D; Vollenweider FX
    Neuropsychopharmacology; 2001 Mar; 24(3):240-52. PubMed ID: 11166515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission.
    Perry W; Feifel D; Minassian A; Bhattacharjie I; Braff DL
    Am J Psychiatry; 2002 Aug; 159(8):1375-81. PubMed ID: 12153831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research.
    Geyer MA
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():73-9. PubMed ID: 9754837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol.
    Duncan E; Szilagyi S; Schwartz M; Kunzova A; Negi S; Efferen T; Peselow E; Chakravorty S; Stephanides M; Harmon J; Bugarski-Kirola D; Gonzenbach S; Rotrosen J
    Psychiatry Res; 2003 Aug; 120(1):1-12. PubMed ID: 14500109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania.
    Perry W; Minassian A; Feifel D; Braff DL
    Biol Psychiatry; 2001 Sep; 50(6):418-24. PubMed ID: 11566158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
    Riba J; Rodríguez-Fornells A; Barbanoj MJ
    Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gating and habituation of the startle reflex in schizophrenic patients.
    Braff DL; Grillon C; Geyer MA
    Arch Gen Psychiatry; 1992 Mar; 49(3):206-15. PubMed ID: 1567275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder.
    Cadenhead KS; Geyer MA; Braff DL
    Am J Psychiatry; 1993 Dec; 150(12):1862-7. PubMed ID: 8238643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of the acoustic startle reflex, prepulse inhibition, and habituation in schizophrenia.
    Ludewig K; Geyer MA; Etzensberger M; Vollenweider FX
    Schizophr Res; 2002 May; 55(1-2):129-37. PubMed ID: 11955972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Startle response models of sensorimotor gating and habituation deficits in schizophrenia.
    Geyer MA; Swerdlow NR; Mansbach RS; Braff DL
    Brain Res Bull; 1990 Sep; 25(3):485-98. PubMed ID: 2292046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose ketamine increases prepulse inhibition in healthy men.
    Abel KM; Allin MP; Hemsley DR; Geyer MA
    Neuropharmacology; 2003 May; 44(6):729-37. PubMed ID: 12681371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of increased central serotonergic activity on prepulse inhibition and habituation of the human startle response.
    Jensen KS; Oranje B; Wienberg M; Glenthøj BY
    Neuropsychopharmacology; 2007 Oct; 32(10):2117-24. PubMed ID: 17299503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.